FR2362849A1 - NEW HETEROCYCLO-OMEGA-PENTANORPROSTAGLANDINS ARYLIC SUBSTITUTES IN POSITION 2 AND MEDICINAL PRODUCTS CONTAINING THEM - Google Patents

NEW HETEROCYCLO-OMEGA-PENTANORPROSTAGLANDINS ARYLIC SUBSTITUTES IN POSITION 2 AND MEDICINAL PRODUCTS CONTAINING THEM

Info

Publication number
FR2362849A1
FR2362849A1 FR7726092A FR7726092A FR2362849A1 FR 2362849 A1 FR2362849 A1 FR 2362849A1 FR 7726092 A FR7726092 A FR 7726092A FR 7726092 A FR7726092 A FR 7726092A FR 2362849 A1 FR2362849 A1 FR 2362849A1
Authority
FR
France
Prior art keywords
pentanorprostaglandins
heterocyclo
omega
new
arylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7726092A
Other languages
French (fr)
Other versions
FR2362849B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2362849A1 publication Critical patent/FR2362849A1/en
Application granted granted Critical
Publication of FR2362849B1 publication Critical patent/FR2362849B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Abstract

Nouvelles hétérocyclo- omega -pentanorprostaglandines aryliques substituées en position 2. L'invention concerne également la préparation de ces composés. Ces composés exercent comme les prostaglandines divers effets physiologiques utiles à la médecine humaine et à la médecine vétérinaire.New aryl heterocyclo-omega-pentanorprostaglandins substituted in position 2. The invention also relates to the preparation of these compounds. These compounds exert, like prostaglandins, various physiological effects useful in human medicine and veterinary medicine.

FR7726092A 1976-08-27 1977-08-26 NEW HETEROCYCLO-OMEGA-PENTANORPROSTAGLANDINS ARYLIC SUBSTITUTES IN POSITION 2 AND MEDICINAL PRODUCTS CONTAINING THEM Granted FR2362849A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71810776A 1976-08-27 1976-08-27

Publications (2)

Publication Number Publication Date
FR2362849A1 true FR2362849A1 (en) 1978-03-24
FR2362849B1 FR2362849B1 (en) 1980-07-11

Family

ID=24884845

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7726092A Granted FR2362849A1 (en) 1976-08-27 1977-08-26 NEW HETEROCYCLO-OMEGA-PENTANORPROSTAGLANDINS ARYLIC SUBSTITUTES IN POSITION 2 AND MEDICINAL PRODUCTS CONTAINING THEM

Country Status (9)

Country Link
JP (1) JPS5328159A (en)
BE (1) BE858147A (en)
DE (1) DE2737808A1 (en)
DK (1) DK379477A (en)
FR (1) FR2362849A1 (en)
GB (1) GB1542569A (en)
IE (1) IE46257B1 (en)
LU (1) LU78037A1 (en)
NL (1) NL7709444A (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1269786A (en) * 1997-09-09 2000-10-11 普罗克特和甘保尔公司 Aromatic C16-C20 substituted tetrahydro prostaglandins useful as EP agonists
PL339221A1 (en) * 1997-09-09 2000-12-04 Procter & Gamble Aromatic c16-c20-substituted tetrahydroprostaglandines useful as fp agonists
NZ503736A (en) * 1997-09-09 2002-06-28 Procter & Gamble Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists
JP4834224B2 (en) 1999-03-05 2011-12-14 デューク ユニバーシティ C16 unsaturated FP-selective prostaglandin analogs
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
JP6111672B2 (en) * 2013-01-10 2017-04-12 株式会社ニコン Photomask substrate and photomask

Also Published As

Publication number Publication date
JPS5539554B2 (en) 1980-10-13
BE858147A (en) 1978-02-27
NL7709444A (en) 1978-03-01
DK379477A (en) 1978-02-28
IE46257B1 (en) 1983-04-20
JPS5328159A (en) 1978-03-16
DE2737808A1 (en) 1978-03-16
LU78037A1 (en) 1979-05-23
IE46257L (en) 1978-02-27
GB1542569A (en) 1979-03-21
FR2362849B1 (en) 1980-07-11

Similar Documents

Publication Publication Date Title
NO931267L (en) PROCEDURE FOR TREATMENT OR PREVENTION OF TYPE 1DIABETES BY ORAL ADMINISTRATION OF INSULIN
DE3382641D1 (en) MEDICINAL PRODUCTS FOR THE TREATMENT OF ALOPEZIA.
FR2392971A1 (en) PROSTANOIC ACID DERIVATIVES, THEIR PREPARATION AND MEDICINAL PRODUCT CONTAINING SUCH SUBSTANCES
FR2387220A1 (en) BENZIMIDAZOLE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING IT
NO173998C (en) Analogous Procedures for Preparing Therapeutically Active Benzimidazole Derivatives
IT8322855A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE.
FR2391215A1 (en) NEW IMIDAZOAZINES AND IMIDAZODIAZINES, THEIR PREPARATION AND APPLICATION AS MEDICINAL PRODUCTS
FR2404634A1 (en) THIAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS IN CONTAINER
FR2362849A1 (en) NEW HETEROCYCLO-OMEGA-PENTANORPROSTAGLANDINS ARYLIC SUBSTITUTES IN POSITION 2 AND MEDICINAL PRODUCTS CONTAINING THEM
FR2450839B1 (en) PYROPHOSPHATE COMPLEXES OF ETHYLENEDIAMINE PLATINUM (II) AND 1,2-DIAMINOCYCLOHEXANEPLATIN (II) USEFUL AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2358382A1 (en) NEW NONAPEPTIDES, THEIR METHODS OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2379533A1 (en) TETRAZOLYLCARBAMOYLQUINOLEINS FOR USE AS MEDICINAL PRODUCTS AND THEIR PREPARATION
DE69111974D1 (en) Use of lithium for the treatment or prophylaxis of Molluscum contagiusum.
FR2355007A1 (en) (3-LOWER ALCOYL-AMINO-2-R, 10 SUBSTITUTED PROPOXY PYRIDINES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
MX9203361A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING GALIUM CHLORIDE.
FR2401139A2 (en) NEW D5 DERIVATIVES OF PROSTAGLANDINS, THEIR PREPARATION PROCESS AND MEDICINAL PRODUCTS CONTAINING THEM
BE830577A (en) ACETIC ACID ACTIVE DERIVATIVES, THERAPEUTIC COMPOSITIONS CONTAINING THEM AND THE PROCESSES FOR THE PREPARATION OF THESE DERIVATIVES AND COMPOSITIONS
FR2375211A1 (en) NEW SULFAMOYLBENZOIC ACIDS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2428649A1 (en) DIESTERS IN 17,21 OF HYDROCORTISONE AND MEDICINAL PRODUCTS CONTAINING SAME
FR2422647A1 (en) NEW 2,4-DIAMINO-5-BENZYLPYRIMIDINES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
NO862321D0 (en) PHYSIOLOGICAL AGENT FOR INCREASING TRANSDERMAL DELIVERY OF MEDICINAL PRODUCTS.
FR2366289A1 (en) NEW DERIVATIVES OF IMIDAZO (5,1-A) ISOQUINOLEINE, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2373561A1 (en) CORTICOSTEROIDS AND MEDICINAL PRODUCTS CONTAINING THEM
FR2394539A1 (en) NEW DERIVATIVES SUBSTITUTED IN POSITION 15 OF O-PENTANORPROSTAGLANDIN AND THEIR USE AS A MEDICINAL PRODUCT
FR2381786A1 (en) NEW ARYL-HEXAFURANOSIDES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS

Legal Events

Date Code Title Description
ST Notification of lapse